GLP-1.app
The basics

GLP-1 half-life: how long semaglutide and tirzepatide stay in your system

A medicine's half-life tells you how fast your body clears it. Here is what the term means in plain words, the half-life each US label lists for the main GLP-1 medicines, and what an estimated level chart can and cannot tell you.

Illustration of an hourglass.
The short version
  • The US labels list a half-life of about 1 week for semaglutide (Wegovy, Ozempic, Rybelsus) and about 5 days for tirzepatide (Zepbound, Mounjaro).1,2,3,4,5
  • Levels build up over the first weeks: the labels say steady levels arrive after about 4 to 5 weeks for semaglutide and 4 weeks for tirzepatide.2,3,4
  • After the last dose, semaglutide stays in the blood for about 5 weeks (Ozempic label) to 5 to 7 weeks (Wegovy label). An estimated level chart is a model, not a blood test.1,2

What is a GLP-1 half-life?

A medicine's half-life is the time it takes for the amount in your body to fall by half.8 If a drug has a half-life of one week, half of it is gone after one week, half of what is left is gone after the next week, and so on. GLP-1 medicines have long half-lives, measured in days, which is why most are taken once a week. The half-life numbers below come from section 12.3, "Pharmacokinetics", of each US label. Pharmacokinetics simply means how the body absorbs, spreads and clears a drug.

An everyday comparison: think of a phone that loses half of its remaining charge every week while switched off. The analogy stops working in two places. Your body first has to absorb the dose, so levels rise for a day or more before they fall. And people clear drugs at different speeds, so the "battery" drains faster for some than for others.

Illustration of a descending curve across weekly calendar squares.

How fast does the level fall after one dose?

Most medicines, GLP-1s included, follow what pharmacologists call first-order elimination: the body removes a fixed share, not a fixed amount, in each half-life.8 That gives a simple pattern after a single dose, counted from its peak:

Peak100%
1 half-life50%
2 half-lives25%
3 half-lives12.5%
4 half-lives6.25%
5 half-lives~3%

This is plain arithmetic from the definition. It is why a common rule of thumb says about five half-lives clears most of a drug: about 97% is gone. A 2025 review notes that, based on pharmacokinetic studies, women are routinely advised to stop a GLP-1 medicine five half-lives before trying to conceive.9 For semaglutide, with a half-life of about a week, five half-lives is about five weeks. That matches the Ozempic label's statement that semaglutide is present in the circulation for about 5 weeks after the last dose.2

Half-life of each GLP-1 medicine

MedicineHalf-life (label)Peak after a doseSteady level reached
Natural GLP-1 (the body's own hormone)1.5 to 2 minutesn/an/a
Liraglutide (Victoza, Saxenda), daily shotabout 13 hours8 to 12 hoursnot stated
Dulaglutide (Trulicity), weekly shotabout 5 days24 to 72 hours2 to 4 weeks
Tirzepatide (Mounjaro, Zepbound), weekly shotabout 5 days (Mounjaro); 5 to 6 days in overweight or obesity (Zepbound)8 to 72 hours4 weeks
Semaglutide shot (Ozempic, Wegovy), weeklyabout 1 week1 to 3 days4 to 5 weeks (Ozempic label)
Semaglutide tablet (Rybelsus, Ozempic tablets, Wegovy tablets), dailyabout 1 weekabout 1 hour4 to 5 weeks (Rybelsus label)
Source: section 12.3 of each current US label (12.1 for natural GLP-1).1–7

Why do the medicines last so long when the natural hormone lasts minutes? The Victoza label explains that natural GLP-1 is broken down within 1.5 to 2 minutes by enzymes such as DPP-4, which the medicine resists.6 Semaglutide and tirzepatide also stick to albumin, a common protein in the blood. The labels say this slows how fast the kidneys clear them and protects them from breakdown.2,4

The tablets are a special case. Semaglutide tablets reach their peak about an hour after you take them, but the drug itself has the same one-week half-life as the shot, so levels still build up and wash out over weeks.1,3 For more on the pill, see oral semaglutide for weight loss.

What is steady state, and when is it reached?

Steady state is the point where the amount you take in each week balances the amount your body clears, so the level stops climbing and moves in the same weekly up-and-down pattern. With a weekly dose and a half-life of about a week, some of last week's dose is still there when the next one goes in, so levels build up over the first several doses.

The labels give the timing directly. Steady levels are reached after 4 to 5 weeks of weekly semaglutide (Ozempic label) or daily semaglutide tablets (Rybelsus label), after 4 weeks of weekly tirzepatide (Mounjaro and Zepbound labels) and after 2 to 4 weeks of weekly dulaglutide (Trulicity label).2,3,4,5,7 These times are for a fixed dose. During the step-up phase, each new dose starts a fresh climb. See the Wegovy and Zepbound dose schedule for how the steps work.

How long does semaglutide stay in your system?

The labels word this slightly differently:

  • Ozempic (section 12.3): about 5 weeks after the last dose.2
  • Rybelsus and Ozempic tablets (section 12.3): about five weeks after the last tablet.3
  • Wegovy (section 12.3): about 5 to 7 weeks after the last 2.4 mg or 7.2 mg shot or 25 mg tablet.1

This long tail is why the Wegovy, Ozempic and semaglutide tablet labels, in section 8.3, tell prescribers to stop the medicine at least 2 months before a planned pregnancy.1,2,3 That is the labels' instruction to prescribers, not personal advice. If you are planning a pregnancy or could be pregnant, talk to your care team before changing anything. Our article on GLP-1s, birth control and pregnancy covers what the labels say about the pill and tirzepatide.

The long half-life also matters for other things. The labels note that after an overdose, observation may need to be long because of the half-life.2,4 And it is part of why missed-dose rules are written in days, not hours; see what the labels say about a missed dose.

What can a GLP-1 level chart or calculator tell you?

Half-life plotters and estimated level charts take your dose dates and apply average label numbers to draw a curve. That can be useful for seeing the general shape: a rise after each dose, a slow fall, a build-up over the first weeks and a long tail after stopping. But it is a model, and it has limits.

  • It uses averages. The Wegovy label shows how wide real levels are. In its model of adults with overweight or obesity without type 2 diabetes, 90% of people on the 2.4 mg weekly shot had average semaglutide levels between 51 and 110 nmol/L. On the 25 mg daily tablet, the range was wider: 27 to 186 nmol/L.1 The Zepbound label lists person-to-person variation of about 20% in how fast tirzepatide is cleared.4
  • It is not a blood test. No home chart measures your actual level, and the labels do not call for measuring blood levels of these medicines.
  • Feelings do not map exactly onto levels. Appetite, nausea and energy depend on many things besides the level on a given day, such as food, sleep and how long you have been on a dose. A chart can help you notice patterns, but it cannot explain every good or bad day.
An estimated level chart is for understanding, not for deciding doses. Do not change when or how much you take based on a chart. Your prescriber sets your dose and schedule.

Key terms in this article

  • Half-life: the time it takes for the amount of a drug in the body to fall by half.
  • Pharmacokinetics: how the body absorbs, spreads and clears a drug (label section 12.3).
  • Peak: the highest level after a dose, before clearing outpaces absorption.
  • Steady state: the point where each dose balances what the body clears, so levels stop building up.
  • Washout: the time it takes for a drug to leave the body after the last dose.
  • Albumin: a common blood protein; semaglutide and tirzepatide bind to it, which makes them last longer.
  • DPP-4: an enzyme that breaks down the body's own GLP-1 within minutes.

Common questions

What is the half-life of semaglutide?

The US labels for Wegovy, Ozempic and Rybelsus list an elimination half-life of about 1 week for semaglutide, for both the weekly shot and the daily tablet. The Ozempic label says semaglutide stays in the circulation for about 5 weeks after the last dose; the Wegovy label says about 5 to 7 weeks after its higher doses.

What is the half-life of tirzepatide?

The US Mounjaro label lists a half-life of about 5 days for tirzepatide, and the Zepbound label lists about 5 to 6 days in people with overweight or obesity. Both labels say steady levels are reached after 4 weeks of weekly doses.

How long does semaglutide stay in your system?

The US Ozempic and Rybelsus labels say semaglutide is present in the circulation for about 5 weeks after the last dose, and the Wegovy label says about 5 to 7 weeks after a 2.4 mg or 7.2 mg shot or a 25 mg tablet. For planned pregnancy, the Wegovy and Ozempic labels say to stop at least 2 months beforehand because of this long washout.

What is the half-life of natural GLP-1?

The body's own GLP-1 hormone lasts only 1.5 to 2 minutes in the blood, according to the US Victoza and Saxenda labels, because enzymes such as DPP-4 break it down quickly. GLP-1 medicines are built to resist those enzymes, which is why they last hours to days.

Is a GLP-1 half-life chart or calculator accurate?

A half-life chart is a model built from average label numbers, not a measurement of your blood. For adults with overweight or obesity without type 2 diabetes, the Wegovy label says 90% of people on the 2.4 mg shot had average semaglutide levels anywhere from 51 to 110 nmol/L, so real levels vary from person to person.

Sources

  1. US prescribing information for WEGOVY (semaglutide) injection and tablets, sections 8.3 and 12.3. DailyMed, revised June 2026.
  2. US prescribing information for OZEMPIC (semaglutide) injection, sections 8.3, 10, 12.1 and 12.3. DailyMed, revised June 2026.
  3. US prescribing information for RYBELSUS and OZEMPIC (semaglutide) tablets, sections 8.3 and 12.3. DailyMed, revised January 2026.
  4. US prescribing information for ZEPBOUND (tirzepatide) injection, sections 10, 12.1 and 12.3. DailyMed, revised August 2026.
  5. US prescribing information for MOUNJARO (tirzepatide) injection, section 12.3. DailyMed, revised August 2026.
  6. US prescribing information for VICTOZA (liraglutide) injection (DailyMed, revised October 2025) and SAXENDA (liraglutide) injection (DailyMed, revised February 2026), sections 12.1 and 12.3.
  7. US prescribing information for TRULICITY (dulaglutide) injection, section 12.3. DailyMed, revised June 2026.
  8. Hallare J, Gerriets V. Elimination Half-Life of Drugs. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025. NCBI Bookshelf · PubMed
  9. Price SAL, Nankervis A. Considering the use of GLP-1 receptor agonists in women with obesity prior to pregnancy: a narrative review. Arch Gynecol Obstet. 2025;311(5):1241-1247. doi:10.1007/s00404-024-07849-9 · Full text (PMC)
This article summarises published research for general information. It is not medical advice and does not replace advice from your own care team. Never change a medication or dose without talking to your prescriber.